tiprankstipranks
Advertisement
Advertisement

GSK Stock Latest News

Trump Trade: U.S. issues 15% duty on products made from polysilicon
The FlyTrump Trade: U.S. issues 15% duty on products made from polysilicon
3d ago
AZN
EBS
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
PremiumThe Fly
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
3d ago
AZN
EBS
GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease
PremiumCompany Announcements
GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease
5d ago
GSK
GSK’s NEBULA-2 Trial Targets MASH Cirrhosis, With Investors Watching Closely
PremiumCompany Announcements
GSK’s NEBULA-2 Trial Targets MASH Cirrhosis, With Investors Watching Closely
5d ago
GSK
GSK closer to relaunching Brexafemme, says Brookline
PremiumThe Fly
GSK closer to relaunching Brexafemme, says Brookline
10d ago
GSK
SCYX
GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank
PremiumThe FlyGSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank
11d ago
GSK
GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum
Premium
Company Announcements
GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum
11d ago
GSK
GSK Advances mRNA RSV Vaccine Program With Completed Phase 1 Study
Premium
Company Announcements
GSK Advances mRNA RSV Vaccine Program With Completed Phase 1 Study
11d ago
GSK
Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV
PremiumThe Fly
Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV
12d ago
GSK
GSK: Solid Quarter but Modest Outlook Prompts Hold Rating and Price Target Lift to £18.90
PremiumRatings
GSK: Solid Quarter but Modest Outlook Prompts Hold Rating and Price Target Lift to £18.90
12d ago
GSK
GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained
PremiumRatings
GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained
12d ago
GSK
GlaxoSmithKline Earnings Call Highlights Record Infrastructure
PremiumCompany Announcements
GlaxoSmithKline Earnings Call Highlights Record Infrastructure
12d ago
GSK
GSK Advances Pan-Salmonella Vaccine Program With New Early-Stage Trial in Africa
PremiumCompany AnnouncementsGSK Advances Pan-Salmonella Vaccine Program With New Early-Stage Trial in Africa
13d ago
GSK
Morning Movers: Corning sinks and Boeing gains after quarterly results
Premium
The Fly
Morning Movers: Corning sinks and Boeing gains after quarterly results
13d ago
BA
KO
GSK sees 2031 sales over GBP 40B
Premium
The Fly
GSK sees 2031 sales over GBP 40B
13d ago
GSK
GSK sees 70p per share dividend for FY26
PremiumThe Fly
GSK sees 70p per share dividend for FY26
13d ago
GSK
GSK initiates ‘Accelerate Growth’ program
PremiumThe Fly
GSK initiates ‘Accelerate Growth’ program
13d ago
GSK
GSK reports Q2 core EPS 50.5p, up 9% at CER
PremiumThe Fly
GSK reports Q2 core EPS 50.5p, up 9% at CER
13d ago
GSK
GSK sees FY26 core EPS growth 7%-9%
PremiumThe Fly
GSK sees FY26 core EPS growth 7%-9%
13d ago
GSK
GSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study
PremiumThe FlyGSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study
14d ago
GSK
GSK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
GSK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
15d ago
GSK
GSK Discloses July 22 Executive ADS Acquisition by U.S. President
Premium
Company Announcements
GSK Discloses July 22 Executive ADS Acquisition by U.S. President
17d ago
6K
GSK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >